Cambridge Trust’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-185
Closed -$12.2K 698
2023
Q4
$12.2K Buy
+185
New +$11.6K ﹤0.01% 561
2023
Q2
Sell
-1,220
Closed -$70.7K 732
2023
Q1
$70.7K Hold
1,220
﹤0.01% 402
2022
Q4
$88K Sell
1,220
-113
-8% -$8.09K ﹤0.01% 388
2022
Q3
$81K Buy
1,333
+223
+20% +$14.2K ﹤0.01% 398
2022
Q2
$70K Hold
1,110
﹤0.01% 446
2022
Q1
$78K Sell
1,110
-288
-21% -$19.5K ﹤0.01% 466
2021
Q4
$87K Buy
+1,398
New +$87.7K ﹤0.01% 438
2015
Q3
Sell
-4,320
Closed -$216K 228
2015
Q2
$216K Buy
+4,320
New +$205K 0.02% 211

Other funds holding MET

Cambridge Trust's MET Position: Q1 2024 in Review

Cambridge Trust sold out of MetLife (MET) in Q1 2024, closing a stake of 185 shares — an estimated $12.2K sold.

Cambridge Trust first reported a position in MET in Q2 2015 and held it in 8 quarters. The position peaked at $216K in Q2 2015. 1,281 funds tracked by Wall St. Rank hold MET as of Q1 2024.

  • Cambridge Trust reported no remaining MetLife position as of Q1 2024 after selling out during the quarter.
  • Cambridge Trust sold 185 MetLife shares in Q1 2024, an estimated $12.2K.
  • Cambridge Trust first reported a position in MetLife in Q2 2015 and held it in 8 quarters.
  • Cambridge Trust's MetLife position peaked at $216K in Q2 2015.
  • 1,281 funds tracked by Wall St. Rank held MetLife as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.